Overview
- Independent arbitrator Martin F. Scheinman denied the MLBPA grievance, keeping the 80-game ban in place.
- Rojas is eligible to return on June 25, 2026 and cannot appear on the 2026 postseason roster.
- The suspension is without pay and is projected to cost him $395,305 in salary.
- The Phillies said they are disappointed and expressed support for MLB’s drug program as Justin Crawford is expected to handle center field with Brandon Marsh and Pedro León among depth options.
- The case extends a recent run of PED suspensions linked to the franchise, and a reporter briefly misidentified Miguel Rojas before correcting the record.